Antioxidant and Hepatoprotective properties of Terminalia arjuna Bark on Isoniazid Induced Toxicity in Albino rats

 

P. Doorika and T. Ananthi*

P.G. Department of Biochemistry, S.T.E.T Women’s College, Mannargudi – 614 601.

*Corresponding Author E-mail: elangani576@ gmail.com

 

ABSTRACT:

The aqueous extract of Terminalia arjuna bark was investigated for its hepatoprotective effect against isoniazid induced acute liver damage on albino rats. Isoniazid (100mg/kg) significantly elevated the serum levels of biochemical markers like SGPT, SGOT, ALP, ACP, Bilirubin, Protein and depleted antioxidant enzymes GSH and SOD upon administration of Isoniazid (100mg/kg) to albino rats. This indicated that there the aqeous extract of bark of Terminalia arjuna at 200mg/kg dose significantly reduced the elevated levels of biochemical markers mentioned above. Test extract treatment also increased the level of SOD and GSH. These results suggest that aqueous extract of Terminalia arjuna may have the potential therapeutic value in the treatment of Isoniazid induced hepatic damage and some liver diseases. Hepatoprotective activity of the study plant may be attributed to the anti-oxidant principles in it.

 

KEY WORDS: Terminalia arjuna, Isoniazid, Hepatoprotective, antioxidant

 


INTRODUCTION:

The liver is largest glandular organ in the body and weight 1.5kg making up about 2-3% of the total body weight. It is responsible for detoxifying the poisonous substances in the body by transforming and removing toxins and wastes. The liver serves a variety of functions. The most crucial is its role in the body’s metabolism. There is no organ is more important to healthy metabolism than the liver in many ways (Robbins et al., 2003).

 

Liver disease is a collective term for a whole group of problems that afflict the tissues, structures and cells of the human liver. The liver performs a multitude of important functions, so there’s plenty of opportunity for something to go wrong. One of the most common causes of liver disease is inflammation, which often results from abuse of alcohol, poor diet or even malnutrition (Arias et al., 1989).

 

Drug induced liver injury is the major health problem that challenges not only care health professional but also the pharmaceutical industry and drug regulatory agencies. According to the United States Acute Liver Failure Study Group, drug induced liver injury accounts for more than 50% of acute liver failure, including hepatotoxicity caused by over dose of acetaminophen (39%) and idiosyncratic liver injury triggered by other drugs (Micheale and Cynthiya, 2006) .

 

Medicinal herbs are significant source of pharmaceutical drugs. Latest trends have shown increasing demand of phyto drugs and some medicinal herbs have proven hepato protective potential. Medicinal herbs and extracts prepared from them are widely used in the treatment of liver diseases like hepatitis, cirrhosis, and loss of appetite (Nadkarni and Nadkarni, 1954).

 

Terminalia arjuna is a deciduous and ever green tree, standing 20-30m above ground level. It belongs to Combretaceae family (Chopra and Ghosh, 1929).  It is found in Uttar Pradesh, South Bihar, Madhya Pradesh, Delhi and Deccan region near ponds and livers. Ancient Indian physicians used the powdered tree bark of Terminalia arjuna for alleviating “Hritshool” (angina) and other cardiovascular conditions. Its stem bark possesses glycosides, large quantities of  flavonoids, tannins and minerals. Flavonoids have been detected to exert antioxidant, anti inflammatory and lipid lowering effects while glycosides are cardiotonic, thus making Terminalia arjuna unique amongst currently used medicinal plants.

 

MATERIALS AND METHODS:

Collection of plant materials:

The plant material Terminalia arjuna was collected from Trichy district which was carefully identified with the help of regional floras.

 

Extraction of plant material:

Aqueous extract was prepared according to the methodology of Indian pharmacopoeia. The shady dried plant materials were subjected to pulverization to get coarse powder. The coarse powder material was subjected to sox let extraction separately and successively with distilled water. These extract was concentrated to dryness in flash evaporator under reduce pressure and controlled temperature (40 – 50o C). The aqueous extract put in air tight containers stored in refrigeration.

 

Phytochemical analysis:

Phytochemical analysis for major phytoconstituents of the plant extract was undertaken using standard methods .The plant was screened for the presence of biologically active compounds like sugars, amino acids, proteins, phenols, terpenoids, etc.

 

Collection of animal species:

The healthy young adult female rats (120-200gm sex) were kept separately in individual polypropylene cages with stainless steel hopper. The females was nulliparous and non pregnant, at the commencement of the study, the weight of the animals were minimal and not exceed ± 20% of the mean weight.

 

Experimental hepatotoxicity:

Isoniazid (100 mg/kg body weight) solution was prepared separately in sterile distilled water. Rats were treated with Isoniazid, administered for 10 days by IP route (Jing et al., 2004).

 

In order to the study the effect of aqueous extract of  bark of Terminalia arjuna in rat 200mg/kg.bwt (Gupta et al., 2005). Rats were divided into four groups.

 

Experimental design:

Albino rats of either sex between 120-200g were randomly assigned into 4 groups of 6 animals each. Group-I (Negative control) received 1ml/kg normal saline, Group-II (Isoniazid 100mg/kg), Group-III (200mg/kg aqeous extract only) and Group-IV (treated 200mg/kg  aqeous extract after induction  with Isoniazid) were treated with respective treatments for 20 days. The blood samples were drawn from all the animals by puncturing retro-orbital plexus on 20th day of the treatment. The blood samples were centrifuged immediately to get clear serum and subjected for estimation of various biochemical parameters namely SGPT (Reitman and Frankel, 1957), SGOT (King and King, 1954), ALP, ACP (Committee on enzymes of the Scandinavian society), and Serum protein (Lowry et al., 1951), Serum Bilirubin (Malloy and Evelyn, 1937), SOD (Kakkar and Viswanathan, 1998) GSH (Griffith1980).

 

Statistical Analysis:

The value are reported are means + SD (n=6). Experimental results were statistically analyzed using the variance (ANOVA) by student t’ test.

 

RESULTS AND DISCUSSION:

Preliminary phytochemical Screening:

The plant extract of Terminalia arjuna were screened for the presence of biologically active compounds like steroids, tannins, phenolics compound, quinone, terpinoids, sugar, alkaloids and flavonoids (Table 1).

 

Table I : Preliminary phytochemical investigation in the aqueous extract of bark of Terminalia arjuna

Phytochemical compound

Result of qualitative test

Sugar

+

Terpinoids

+

Alkaloids

+

Phenolic compounds

+

Tannins

+

Flavanoids

+

Volatile oil

-

Quinones

+

Steroids

+

Coumarins

-

+ indicates presence; - indicates absence

 

Serum Protein:

A significant increase (p<0.01) in serum protein level was noted in group III when compared to Group II. Also there was a significant increase (p<0.05) in serum protein level in group IV when compared to Group II. Thus the restoration of the level of serum and tissue protein after the administration of Terminalia arjuna confirmed the hepatoprotective nature of it (Table II).

Previous studies on the hepatoprotective effect of Terminalia chebula extract against antipyretic drug induced hepatotoxicity proved that the extract exhibited hepatoprotective nature by restoring the total serum protein level (Gujarti et al., 2006).

 

Serum Bilirubin:

A significant increase (p<0.05) in serum bilirubin levels in Group II was observed when compared to Group I. A significant decrease (p<0.05) in serum bilirubin level was noted in group IV when compared to Group II. But there was no significant change when Group I was compared with Group IV (Table II).

Bilirubin concentrations have been used to evaluate chemically induced hepatic injury (Giuseppe cooper et al., 2004). Treatment with Terminalia arjuna extract reduced the elevated level of bilirubin. This is probably due to the presence of highest content of phenolic derivatives that exert bile flow and liver protection. Thus Terminalia arjuna has cholertic activity.

Table II : Estimation of Serum Proteins and Bilirubin

S. No

Groups

Proteins (mg/g)

Bilirubin (µm/mg)

1.

Group I

0.91±0.4

1.59±0.91

2.

Group II

0.61±0.3

4.23±1.24

3.

Group III

0.79±0.9

1.88±0.45

4.

Group IV

0.88±0.1

2.02±1.31

Values are means ± SD from 6 rats in each observation.

*<0.05; **<0.01; as compared with Group II. +<0.05,

as compared with normal group.

 

Serum ALP:

Serum level of ALP were increased significantly in group II rat (p<0.05) when compared to Group I. A significant decrease in ALP levels were observed in Group III (p<0.01) and Group IV (p<0.05). (Table III). Elevated levels of serum and tissue alkaline phosphates are indicative of cellular leakage and loss of functional integrity of cell membrane in liver cells (Sethu mathavan et al., 2007). Damage to liver cells cause leakage of cellular enzymes into serum.

In the present study the ALP levels returned to normal by administration of Terminalia arjuna with healing of parenchyma and regeneration of hepatocytes. Previous study on Solanum nigrum reduced the elevated level of ALP in CCl4 included hepatotoxicity  (Ruiz et al., 2008).

 

Serum ACP:

A significant increase (p<0.05) in the levels of serum acid phosphatase level was observed. A significant decrease (p<0.01) in serum acid phosphatase level was seen in Group III when compared to Group II. Similarly, a significant decrease (p<0.05) in ACP levels was noted in Group IV when compared to Group II. But no significant changes were observed between Group I and Group IV (Table III).

 

The abnormal higher level of marker enzymes such as ACP and bilirubin in the serum of CCl4 treated rat indicate damage to hepatic cells (Venukumar and Latha, 2002).In the present study, treatment with Terminalia arjuna extract reduced the elevated levels of ACP . Glycosmis arborea extract overcome the toxic effects of hepatotoxic agents by the lowering the levels of ACP (Gomes et al., 2003).

 

Table III : Estimation of Serum ALP and ACP

S. No

Groups

Serum ALP (KA Units)

Serum ACP(KA Units)

1.

Group I

13.96±0.78

5.68±0.29

2.

Group II

22.92±0.16

11.82±0.31

3.

Group III

15.28±0.98

5.93±0.11

4.

Group IV

19.96±0.21

9.86±1.05

Values are mean ± SD from 6 rats in each observation. *<0.05; **<0.01; as compared with Group II. 

+<0.05, as compared with normal group

 

SGOT:

A significant increase in SGOT activity (p<0.05) was noted in Group II when compared to Group I. A significant decrease (P<0.05) in serum SGOT level was observed in Group III when compared to Group II. Also a significant decrease (P<0.05) in serum SGOT level in Group IV was noted when compared to Group II (Table IV).

The Isoniazid has got hepatotoxic potentical (Yew et al., 2006). Isoniazid metabolite hydrazine plays an important role in inducing hepatotoxicity (Al-Howiriny et al., 2004). Isoniazid hepatotoxicity results in hepatocellular damage, thus variety of enzymes normally located in the cytosol are released into blood stream. The elevated level of SGOT due to Isoniazid hepatotoxicity was normalized by treatment with Terminalia arjuna. This is probably because of free radical scavenging activity of flavonoids and polyphenols present in Terminalia arjuna.

 

SGPT:

An increased level of SGPT (p<0.05) was found in Group II rat when compared with Group I. A significant decrease (p<0.01) in serum SGPT level was noted in Group III when compared to Group II. Also there was a significant decrease (p<0.05) in serum SGPT level in Group IV when compared to Group II. But there was no significant change between Group I and Group IV (Table IV).

The normalization of plasma  alanine amino transferase (SGPT) has been proved to be a strategy for preventing the development of hepatocellular carcinoma in hepatitis C virus (HCV) infection. In the present study treatment with Terminalia arjuna extract normalized the elevated SGPT levels. Osthole, a simple coumarin caused strong reduction of plasma SGPT and exhibited hepatoprotective nature  (Okamoto et al., 2005).

 

Table IV: Estimation of Serum SGOT and SGPT

S. No

Groups

Serum SGOT (IU/L)

Serum SGPT (IU/L)

1.

Group I

16.28±2.09

6.96±0.75

2.

Group II

32.54±1.28

12.33±0.58

3.

Group III

17.29±1.33

6.99±0.55

4.

Group IV

19.36±2.92

7.38±1.29

Values are mean ± SD from 6 rats in each observation. *<0.05; **<0.01; as compared with Group II. +<0.05, as compared with normal group.

 

SOD:

There was a significant decrease (p<0.05) in SOD levels in Group II when compared to Group I. A significant increase (p<0.01) in serum SOD level was noted in Group III when compared to Group II. Also there was a significant decrease (p<0.05) in serum level was noted in Group IV when compared to group II. But there was no significant change between Group I and Group IV (Table V).

SOD is very effective antioxidant enzyme and responsible for catalytic disputation of highly reactive and potentially toxic superoxide radicals to H2O2.The H2O2 is further metabolized either by catalase or peroxidase. The non enzymatic antioxidants such as GSH, Vit.E and Vit.C act as scavengers (Foyer et al., 1993).

 

GSH:

There was a significant decrease (p<0.05) in level of Reduced Glutathione in Group II when compared to Group I. A significant increase (p<0.01) in level of Reduced Glutathione was noted in Group III when compared to Group II. Also there was a significant increase (p<0.05) in level of reduced glutathione in Group IV. When compared to Group II. But there was no significant change between Group I and Group IV.

 

GSH in the cytosolic pool consists of 85% hepatocellular GSH and 15% mitochondrial GSH. Hepatic GSH depletion or even extra hepatic GSH depletion can provide useful information on the protective role of GSH against toxic foreign compounds. Thus GSH, be regarded as an endogenous protective agent against drugs (Chattopadhyay, 1992).

 

Table V : Estimation of Serum SOD and GSH

S. No

Groups

Serum SOD (mg/dl)

Serum GSH (mg/dl)

1.

Group I

5.33±0.97

4.38±0.22

2.

Group II

4.14±0.28

2.23±0.24

3.

Group III

5.30±0.21

4.78±0.45

4.

Group IV

5.16±2.01

5.15±1.31

Values are mean ± SD from 6 rats in each observation. *<0.05; **<0.01; as compared with Group II. +<0.05, as compared with normal group.

 

CONCLUSION:

The present findings demonstrated the hepatoprotective and antioxidant effect of Terminalia arjuna aqueous bark extract against Isoniazid induced hepatotoxicity. According to traditional indigenous medicinal systems of India this plant has got several medicinal effects without producing any severe side effects. This plant could be very well used as hepato protectant. However this is only a tentative research and more work is to be done to identify the extract phytochemical responsible for this curative effect.

 

REFERENCES:

 

1.        Al-Howiriny TA, Al-Sohaibani MO, Al-Said MS, Al-Yahya MA., Tahir KH.  and Rafatullah S. Hepatoprotective properties of Commiphora opobalsamum (“Balessan”), a traditional medicinal plant of Saudi Arabia. J. Drugs-Exp-Clin-Res., 30 (5-6); 2004: 213-20.

2.        Arias PS, Bessey AA, Lowery DM and Brock M. Lipid peroxidation Biochemistry measurement and significance in liver cell injury. Indian. J. Exp. Biol., 45; 1989: 87-89.

3.        Chattopadhyay RR, Sarkar SK, Ganguly S, Medda C and Basu TK. Hepatoprotective activity of Ocimum sanctum leaf extract against paracetamol induced hepatic damage in rats. J. Ethnopharmacol., 24; 1992:163.

4.        Chopra RN and Ghosh S. Terminalia arjuna: its chemistry, pharmacology and therapeutic action. Indian Medical Gazette, 64; 1929: 70-73.

5.        Foyer CH, Alscher RG, Hess JL. Antioxidants in higher plants. Boca Raton CRC Press 1993; 3158.

6.        Gilan S, Deduce C., Singh J, Hussain Janbaz MS. Evaluation of the protection potential of Agave Americana extract on acetaminophen induced liver injury.2002.

7.        Giuseppe Cooper JR, Bloom F.E.  and Roth R.H.. Hepatopharmacological study of Agave Americana linn in thioacetamide induced liver damage in rats. Indian Medicinal Plants. 2004: 10-12.

8.        Gomes M, Das P, Besra SE, Chakravorty A, Das B, Ganguly  DK and Vedasiromoni JR. Glycosmis arborea extract as a hepatoprotective agent. Phytother. Res., 17(5); 2003: 571-74.

9.        Griffith O. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal Biochem., 106; 1980: 207.

10.     Gujarti S, Nigerians K, Pandima Devi M, Sreepriya K and. Balakrishnan K. Protective activity Tylophora indica extract on paracetamol induced liver damage. I. J. of Ethnopharmacology, 3; 2006: 95-100.

11.     Gupta RK, Kesari AN, Murthy PS, Chandran R, Tandon V and  Wata G. Antihyperglycemic activity of Ficus deltoidea ethanolic extract in normal rats. J. Ethnopharmacol., 99(1); 2005: 75-81.

12.     Jing TUE, Ren-xiu ENG, Jing YANG, Rui. CYP2E1 isoniazid induced hepatotoxicity in rats. Acta Pharmacol Sin., 25(5); 2004: 699-704.

13.     Kakkar P, Das B, Viswanathan PN. A modified spectrophoto metric assay of superoxide dismutase. Indian J. Biochem. Biophys 21; 1998: 130132.

14.     King PRN and King EJJ. Estimation of plasma phosphatase by determination of hydrolyzed phenol with aminopyrines. J. Clin. Pathol., 7; 1954: 332.

15.     Lowry OH, Rosebrough NJ, Farr A and Randall RJ. Protein measurement with the Folin phenol reagent, J. Biol Che.,193;1951:265.

16.     Malloy HT, Evelyn KA. The determination of  bilirubin with the photometric colorimeter. J. Biol. Chem., 119; 1937:  481.

17.     Micheale P, Cynthiya Ju. Mechanism of Drug induced liver injury. The AAPS Journal., 1; 2006: 48-54.

18.     Nadkarni AK, Nadkarni KM. Indian Materia Medica. First ed. Popular Book Deport. Bomaby India, 1954:1198.

19.     Okamoto Nadro,  Rall,  Eteng Mu, Hepatoprotective effect of Balamites agyptiaca against the liver damage. I. J. of Pharmacol. Sci, 30; 2005: 148-151.

20.     Reitman S, Frankel S. Colorimetric method for the determination of serum glutamatic oxaloacetic acid and glutamic pyruvic transaminases. Am. J. Clin. Pathol., 28; 1957:56.

21.     Robbins J, Fleurentin C, Hefler A. Hepatoprotective properties of crepisrueppelli and anisotes Trisules. Journal of ethanopharmacology., 76; 2003: 105-111.

22.     Ruiz-Term F, Merdrano-Martinez A and Navaroo Ocana. Antioxidant and free radical scavenging activities of plant extract used in traditional medicine in mexico. African Journal of Biotechnology. 7(12): 2008; 1886.

23.     Sethumadhavan, S., Theruvathil, S., Rangaswamy, A., Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. European J. Pharmacol. Xx; 2007: XXX-XXX.

24.     The committee on enzymes of the Scandinavian society for clinical chemistry and clinical Physiology, Recommended method for determination of fourenzymes in blood, J Clin. Lab. Invest. 33; 1974: 291-98.    

25.     Venukumar  MR. and Latha MS. Antioxidant activity of Ballota glandulosissima in CCl4 induced hepatopathy in rats. I. J. of Clin. Biochemi., 17; 2002: 80-87.

26.     Yew AH, Gillani AH, Janbaz KH.  Protective effect of Artemisia scoparia extract against carbon tetra chloride induced hepatotoxicity. Gen Pharmacol., 24(6); 2006:455-58.

 

 

 

 

Received on 30.12.2011          Accepted on 10.01.2012        

© Asian Pharma Press All Right Reserved

Asian J. Pharm. Tech. 2(1): Jan.-Mar. 2012; Page 15-18